20 µg/kg
Species: Bovine · Tissue: Fat
Marker residue: Gamithromycin
Therapeutic class: Anti-infectious agents/Antibiotics
9 authorised products across national registers.
United States — FDA Green Book
United Kingdom — VMD
Canada — Health Canada DPD
Species: Bovine · Tissue: Fat
Marker residue: Gamithromycin
Therapeutic class: Anti-infectious agents/Antibiotics
Species: Bovine · Tissue: Kidney
Marker residue: Gamithromycin
Therapeutic class: Anti-infectious agents/Antibiotics
Species: Bovine · Tissue: Liver
Marker residue: Gamithromycin
Therapeutic class: Anti-infectious agents/Antibiotics
Species: Cattle · Tissue: Liver (target tissue)
Species: Cattle · Tissue: Muscle
No antimicrobial-resistance surveillance is recorded for this substance.
Spontaneous adverse-event reports that name Gamithromycin, by species — reported counts, not proven reactions.
Top reactions: Death (197) · Lack of efficacy (bacteria) - NOS (97) · Lack of efficacy - NOS (93) · Injection site swelling (35) · Lameness (20)
Source: openFDA Animal & Veterinary adverse-event reports.
Reading about Gamithromycin? Pet products get recalled all the time — get a free email when a new pet-relevant recall is published. Unsubscribe any time.
Opt-in only: we store your email, language, optional species filter and the page you signed up on, and send a welcome email with a one-click unsubscribe link. We never share your address.